SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-16-556422
Filing Date
2016-04-26
Accepted
2016-04-26 16:06:41
Documents
6
Period of Report
2016-04-26

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d166496d6k.htm 6-K 9797
2 EX-99.1 d166496dex991.htm EX-99.1 22361
3 EX-99.2 d166496dex992.htm EX-99.2 658984
4 GRAPHIC g166496g0426071350713.jpg GRAPHIC 2945
5 GRAPHIC g166496g0426073315588.jpg GRAPHIC 3974
6 GRAPHIC g166496snap1.jpg GRAPHIC 20961
  Complete submission text file 0001193125-16-556422.txt   730955
Mailing Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 5 HELLERUP G7 DK-2900 45 36 94 44 86
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 161592074
SIC: 2834 Pharmaceutical Preparations